Efavir 600 Tablet

Efavir 600 Tablet – Efavirenz (600mg)

Efavir 600 Tablet contains Efavirenz 600mg, a non-nucleoside reverse transcriptase inhibitor (NNRTI) manufactured by Cipla Ltd. It is used in combination with other antiretroviral drugs as part of a complete regimen to treat HIV-1 infection.

Key Features

• Single-agent NNRTI antiretroviral tablet, made by Cipla
• Contains Efavirenz 600mg
• Used in combination ART regimens for HIV-1
• Once-daily dosing, usually at bedtime
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Efavirenz (600mg)

Uses & Benefits

• Used in combination with other antiretrovirals to treat HIV-1 infection
• Helps block HIV replication as part of a broader ART regimen
• Supports long-term suppression of viral load
• Prescribed as part of a structured, physician-supervised regimen

Directions for Use

• Take exactly as prescribed by your physician, alongside other prescribed antiretrovirals
• Usually taken once daily at bedtime, on an empty stomach
• Taking at bedtime may help reduce dizziness or vivid dreams
• Do not skip doses to help prevent drug resistance

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.